These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 1291012
1. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children. Can Commun Dis Rep; 1992 Dec 11; 18(23):169-76. PubMed ID: 1291012 [Abstract] [Full Text] [Related]
2. New considerations for Haemophilus influenzae type b vaccination. Pinson JB, Weart CW. Clin Pharm; 1992 Apr 11; 11(4):332-6. PubMed ID: 1563228 [Abstract] [Full Text] [Related]
3. [Effectiveness of Haemophilus influenzae B-diphtheria conjugate vaccination in German children]. Zielen S, Scheurer J, Rhodius U, Schäfer V, Isenberg H, Bauscher P, Schröder S, Ahrens P, Hofmann D. Monatsschr Kinderheilkd; 1992 Dec 11; 140(12):852-6. PubMed ID: 1491705 [Abstract] [Full Text] [Related]
4. Conjugated Haemophilus influenzae type b vaccine. Med Lett Drugs Ther; 1988 Apr 22; 30(764):47-8. PubMed ID: 3258400 [No Abstract] [Full Text] [Related]
5. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B, Wald E, Guerra N, Byers C. Pediatrics; 1990 Apr 22; 85(4 Pt 2):682-9. PubMed ID: 2107519 [Abstract] [Full Text] [Related]
6. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216 [Abstract] [Full Text] [Related]
7. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC. Pediatrics; 2006 Apr 10; 117(4):e717-24. PubMed ID: 16549502 [Abstract] [Full Text] [Related]
8. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. CMAJ; 1993 Jan 15; 148(2):199-214. PubMed ID: 8452591 [No Abstract] [Full Text] [Related]
9. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep; 1991 Jan 11; 40(RR-1):1-7. PubMed ID: 1899280 [Abstract] [Full Text] [Related]
10. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Ahonkhai VI, Lukacs LJ, Jonas LC, Matthews H, Vella PP, Ellis RW, Staub JM, Dolan KT, Rusk CM, Calandra GB. Pediatrics; 1990 Apr 11; 85(4 Pt 2):676-81. PubMed ID: 2107518 [Abstract] [Full Text] [Related]
11. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. Walter EB, Moggio MV, Drucker RP, Wilfert CM. Pediatr Infect Dis J; 1990 Sep 11; 9(9):632-5. PubMed ID: 2235187 [Abstract] [Full Text] [Related]
12. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK, Daum RS. Pediatrics; 1990 Apr 11; 85(4 Pt 2):698-704. PubMed ID: 2107522 [Abstract] [Full Text] [Related]
13. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Pediatrics; 1990 Apr 11; 85(4 Pt 2):690-3. PubMed ID: 2107520 [Abstract] [Full Text] [Related]
14. [When should vaccination against Haemophilus influenzae type b take place?]. Stickl HA. Med Monatsschr Pharm; 1991 Jan 11; 14(1):24. PubMed ID: 2017108 [No Abstract] [Full Text] [Related]
15. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug 11; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
16. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group. Pediatrics; 2009 Jan 11; 123(1):301-12. PubMed ID: 19117896 [Abstract] [Full Text] [Related]
17. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ. Southeast Asian J Trop Med Public Health; 1997 Mar 11; 28(1):91-8. PubMed ID: 9322290 [Abstract] [Full Text] [Related]
18. [Haemophilus vaccines. Their importance in tropical pediatrics]. Bégué P. Bull Soc Pathol Exot; 1991 Mar 11; 84(5 Pt 5):912-6. PubMed ID: 1819437 [Abstract] [Full Text] [Related]
19. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis. Wenger JD, Ward JI, Broome CV. Curr Clin Top Infect Dis; 1989 Mar 11; 10():306-39. PubMed ID: 2679698 [No Abstract] [Full Text] [Related]